The latter combined subgroup showed a marginally significant dose-risk trend for serum α-tocopherol.
← all excerpts
Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.
1
—
—